Grandi et al., 2023 - Google Patents
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccineGrandi et al., 2023
View HTML- Document ID
- 17955001590621979795
- Author
- Grandi A
- Tomasi M
- Ullah I
- Bertelli C
- Vanzo T
- Accordini S
- Gagliardi A
- Zanella I
- Benedet M
- Corbellari R
- Di Lascio G
- Tamburini S
- Caproni E
- Croia L
- Ravà M
- Fumagalli V
- Di Lucia P
- Marotta D
- Sala E
- Iannacone M
- Kumar P
- Mothes W
- Uchil P
- Cherepanov P
- Bolognesi M
- Pizzato M
- Grandi G
- Publication year
- Publication venue
- Vaccines
External Links
Snippet
The vaccination campaign against SARS-CoV-2 relies on the world-wide availability of effective vaccines, with a potential need of 20 billion vaccine doses to fully vaccinate the world population. To reach this goal, the manufacturing and logistic processes should be …
- 229940022962 COVID-19 vaccine 0 title abstract description 14
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shehata et al. | Bacterial outer membrane vesicles (OMVs)-based dual vaccine for influenza A H1N1 virus and MERS-CoV | |
| Anderson et al. | Functional features of the respiratory syncytial virus G protein | |
| Loes et al. | Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice | |
| Li et al. | A novel bacterium-like particle vaccine displaying the MERS-CoV receptor-binding domain induces specific mucosal and systemic immune responses in mice | |
| Aligholipour Farzani et al. | Bovine herpesvirus type 4 (BoHV-4) vector delivering nucleocapsid protein of Crimean-congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in IFNα/β/γR−/− mice models | |
| Zha et al. | Development of a vaccine against SARS-CoV-2 based on the receptor-binding domain displayed on virus-like particles | |
| Chandrasekar et al. | Localized and systemic immune responses against SARS-CoV-2 following mucosal immunization | |
| Bergeron et al. | Respiratory syncytial virus (RSV) G protein vaccines with central conserved domain mutations induce CX3C-CX3CR1 blocking antibodies | |
| Grandi et al. | Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine | |
| Wang et al. | A bivalent COVID-19 vaccine based on alpha and beta variants elicits potent and broad immune responses in mice against SARS-CoV-2 variants | |
| Rabaan et al. | Variants of SARS-CoV-2: Influences on the vaccines’ effectiveness and possible strategies to overcome their consequences | |
| Chu et al. | Influenza virus-like particle (VLP) vaccines expressing the SARS-CoV-2 S glycoprotein, S1, or S2 domains | |
| Zhang et al. | Genetically modified rabies virus vector-based rift valley fever virus vaccine is safe and induces efficacious immune responses in mice | |
| Bernelin-Cottet et al. | A DNA prime immuno-potentiates a modified live vaccine against the porcine reproductive and respiratory syndrome virus but does not improve heterologous protection | |
| Soto et al. | BCG-based vaccines elicit antigen-specific adaptive and trained immunity against SARS-CoV-2 and Andes orthohantavirus | |
| Dubois et al. | Strain-dependent impact of G and SH deletions provide new insights for live-attenuated HMPV vaccine development | |
| Alqazlan et al. | Probiotic lactobacilli limit avian influenza virus subtype H9N2 replication in chicken cecal tonsil mononuclear cells | |
| Sun et al. | Germination-arrest Bacillus subtilis spores as an oral delivery vehicle of grass carp reovirus (GCRV) Vp7 antigen augment protective immunity in grass carp (Ctenopharyngodon idella) | |
| Wang et al. | Evaluation of the immune response afforded by combined immunization with orf virus DNA and subunit vaccine in mice | |
| Shurygina et al. | Preclinical evaluation of TB/FLU-04L—An intranasal influenza vector-based boost vaccine against tuberculosis | |
| Wilmschen et al. | RSV vaccine based on rhabdoviral vector protects after single immunization | |
| Blanco-Lobo et al. | A bivalent live-attenuated vaccine for the prevention of equine influenza virus | |
| Beaudoin-Bussières et al. | A recent SARS-CoV-2 infection enhances antibody-dependent cellular cytotoxicity against Several Omicron subvariants following a fourth mRNA vaccine dose | |
| Esposito et al. | Prevention of congenital cytomegalovirus infection with vaccines: state of the art | |
| Li et al. | Recombinant rabies virus overexpressing OX40-ligand enhances humoral immune responses by increasing T follicular helper cells and germinal center B cells |